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Previously, schizophrenia is found to be related to the variability of the functional magnetic 
resonance imaging (fMRI) signal in the white matter. However, evidence about the relationship 
between genetic vulnerability for schizophrenia and physiological fluctuation in the brain is lacking. 
We investigated whether familial risk for psychosis (FR) and polygenic risk score for schizophrenia 
(PRS) are linked with physiological fluctuation in fMRI data. We used data from the Oulu Brain 
and Mind study (N=140149, aged 2024 years) that is a substudy of the Northern Finland Birth 
Cohort 1986. The participants were scanned with resting-state fMRI. Coefficient of variation (CV) 
of blood oxygen level dependent (BOLD) signal (CVBOLD) was used as a proxy of physiological 
fluctuation in the brain. Participants who had at least one parent with a previous psychosis were 
defined as FRs. PRS was computed based on the results of the prior GWAS by the Schizophrenia 
Working Group. FR or PRS were not associated with CVBOLD in cerebrospinal fluid, white matter, 
or grey matter. The findings did not provide evidence for the previous suggestions that genetic 
vulnerabilities for schizophrenia become apparent in alterations of the variation of the BOLD signal 
in the brain.  
 
Keywords 
Psychosis; Schizophrenia; Polygenic risk score; Familial risk; fMRI; Physiological fluctuation 
 




The strongest known risk factor predicting onset of schizophrenia and other psychotic disorders is 
familial risk (Mäki et al. 2005). Roughly 10% of individuals with a first-degree relative 
with schizophrenia develop the disorder (Gottesman et al. 2010). The heritability estimate of 
schizophrenia is approximately 8090% (Rijsdijk et al., 2011; Sullivan et al., 2003). Recently, 
polygenic risk score for schizophrenia (PRS) has been introduced as a new method to estimate 
genetic risk for developing schizophrenia or other psychotic disorder (Vassos et al. 2016). 
Previously, it has been highlighted that the association of schizophrenia-related genes with 
symptom onset may be mediated via genetically determined alterations in the cerebral physiological 
processes (Birnbaum & Weinberger, 2013). That is, schizophrenia-related genes may predispose to 
neurodevelopmental impairments in the formation of brain networks that, in turn, increase the risk 
for the onset of psychotic symptoms. (Birnbaum & Weinberger, 2013).  
A variety of studies have established that there exist structural and functional brain 
abnormalities in individuals with familial risk for schizophrenia. Meta-analyses of fMRI studies 
have shown that familial risk for psychosis is linked to altered neuronal activity particularly in the 
right temporal and frontal lobes, left thalamus and left cerebellum, and striatum (Cooper et al., 
2014; Fusar-Poli et al., 2007). Additionally, there is evidence that polygenic risk score for 
schizophrenia is related to neural inefficiency in the left dorsolateral prefrontal cortex (Walton et 
al., 2013). In our previous study, we found that high PRS (vs. low PRS) relates to lower inter-
regional correlations of BOLD fMRI signal and grey-matter volume within the face-processing 
network (Lieslehto et al., 2018). 
Usually, functional magnetic resonance imaging (fMRI) studies aim to examine 
neuronal-activation-induced changes in the blood-oxygenation-level-dependent (BOLD) signal 
(Biswal et al., 1996). Importantly, however, the BOLD signal is affected also by a variety of other 
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activities than those of neuronal origin, for example, cerebral blood volume and flow and oxygen 
and carbon dioxide extraction (Cheng et al., 2015; Krüger & Glover, 2001; Murphy et al., 2009; 
Wise et al., 2004). This physiological fluctuation in BOLD signal, however, is traditionally 
regarded as noise variation and is excluded from the fMRI data (e.g. Birn et al., 2012). However, 
physiological fluctuation provides an important viewpoint to essential neurophysiological processes 
in the brain. Specifically, cardiac and respiratory cycles induce pulsations in the brain tissues 
(Kiviniemi et al., 2016; Raitamaa et al., 2018). Moreover, cardiorespiratory frequencies influence 
the flow of cerebrospinal fluid into the ventricles and conduits (e.g. foramina, subarachnoid space, 
interstitial space) (Birn et al., 2012; Dreha-Kulaczewski et al., 2015; Kiviniemi et al., 2016). 
Consequently, it is possible to explore physiological fluctuation in the white matter and 
cerebrospinal fluid, besides of grey matter (Birn et al., 2006, 2012; Birnbaum & Weinberger, 2013).  
Excluding physiological fluctuation from the fMRI data may be a particularly severe 
limitation in the context of schizophrenia research. It is possible that genetic vulnerabilities for 
schizophrenia become apparent in specific alterations of the signal-to-noise ratio of the BOLD 
signal (Harrison & Weinberger, 2005) that refers to the amount of physiological fluctuation in the 
brain. Previously, it has been suggested that physiological fluctuation in the white matter is linked 
with schizophrenia (Cheng et al., 2015) and prodromal symptoms of psychosis (Saarinen et al., 
submitted). Still, however, no study has investigated whether genetic risk for schizophrenia might 
be linked with physiological fluctuation in fMRI data.  
 The aim of the present study was to investigate whether familial risk for psychosis and 
polygenic risk score for schizophrenia might be linked with physiological fluctuation in the brain. 
We used data from the Oulu Brain and Mind study (participants were aged 2024 years) that is a 
substudy of the Northern Finland Birth Cohort 1986. The participants were scanned with resting-
state functional magnetic resonance imaging (r-fMRI). Coefficient of variation (CV) of BOLD-
signal (CVBOLD) was used as an indicator of physiological fluctuation in the brain.  






2.1 Participants  
We used data from the Oulu Brain and Mind Study that is a substudy of the Northern Finland Birth 
Cohort 1986 (NFBC 1986) study. The NFBC 1986 includes individuals with an expected date of 
birth between July 1985 and June 1986 in the two northernmost provinces of Finland. The original 
sample of the NFBC 1986 consisted of 9432 participants. The data collection began prospectively 
before the birth of the participants and has continued since then. For further information of the 
NFBC 1986, see Järvelin et al. (1997). 
The Oulu Brain and Mind Study, a field study with brain-imaging, was conducted in 
20072010 for a subsample of the NFBC 1986. The primary aim of the Oulu Brain and Mind study 
was to examine the early neurophysiological alterations in the brain functioning among young 
individuals with high risk for psychosis. The sample (total N=329) consisted of 5 groups: (i) 
participants with familial risk for psychosis, (ii) participants with symptomatic risk for psychosis, 
(iii) participants with previous psychosis, (iv) participants with attention-deficit/hyperactivity 
disorder, and (v) healthy controls. When selecting the participants for the Oulu Brain and Mind 
study, data from health care registers and previous follow-ups of the NFBC 1986 were used. More 
information about the Oulu Brain and Mind Study is available elsewhere (Veijola et al., 2013). 
The design of the NFBC 1986 study and the Oulu Brain and Mind Study were 
approved by the Ethics Committee of the Northern Ostrobothnia Hospital District in Finland. 
Moreover, the studies were carried out in accordance with the Declaration of Helsinki. All the 
participants provided written informed consent after the nature of the procedures was fully 
explained. 
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In this study, we first excluded all the participants with a positive urine drug test for 
opiates, benzodiazepines, and cannabis (N=22); participants with current use of benzodiazepines, 
neuroleptics, or other non-specified psychiatric medication (N=17); inadequate or missing brain 
scan data (N=12); or missing data about educational level (N=1). This resulted in a sample of 277 
participants. Thereafter, we included in the analyses all the participants with full data on study 
variables (familial risk for schizophrenia or PRS; control variables, i.e. age, sex, educational level, 
and absolute and relative displacement). Consequently, the final sample consisted of 140-149 




2.2.1 Familial risk for psychosis  
Participants with familial risk for psychosis consisted of the NFBC 1986 participants who had at 
least one parent with a non-organic psychosis or cluster A personality disorder 
(paranoid, schizotypal, and schizoid) on the basis of the Finnish Hospital Discharge Register 
(FHDR) between 1972-2005 were invited to this study as participants with familial risk for 
psychosis. Cluster A personality disorders were included because of the genetic closeness to 
schizophrenic psychosis (Tienari et al., 2003). 
The FHDR covers all the Finnish mental and general hospitals, beds in local health 
centres, and private hospitals. During that time ICD-8, ICD-9 and ICD-10 were used, and respective 
ICD codes either from principal or subsidiary diagnoses were collected. The ICD diagnoses used 
for psychotic disorders in ICD-8 and ICD-9 were codes 295–299, 3010, 3012 and in ICD-10: codes 
F20–33 (except non-psychotic mood disorders), F600 and F601. In the NFBC 1986 sample, 
altogether 272 participants with familial risk were detected. Of them, 1 participant died, 5 
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participants were living abroad, and 4 participants could not be reached. Consequently, a total of 
262 individuals with familial risk were sent an invitation letter.  
 
2.2.1 Polygenic risk score for schizophrenia (PRS)  
Detailed information on the collection of the genetic samples and quality control of the genome-
wide data are provided in a previous study (Lieslehto et al., 2018). Briefly, the results of the 
genome wide association studies (GWAS) by the Schizophrenia Working Group of the Psychiatric 
Genomics Consortium (Ripke et al., 2014) were used for the calculation of PRS for schizophrenia 
in the NFBC 1986 sample. We calculated the score on single-nucleotide polymorphisms (SNPs) 
reaching genome-wide significance (p=5×10−8). A total of 112 SNPs were found in the imputed 
NFBC 1986 GWAS dataset. For each participant, we calculated the sum of the risk SNPs multiplied 
by the effect size (logarithm of the odds ratio for schizophrenia) as has been done previously 
(Kendler, 2016). PRS was adjusted for four principal components to account for population 
stratification since the presence of a systematic difference in allele frequencies between 
subpopulations of a population may lead to both type I and II errors (Price et al., 2010). 
 
2.2.3 Participants’ background characteristics 
Background information was collected about participants’ age, sex, educational level, full-scale 
intelligence quotient, smoking status, alcohol use, current Axis-I disorders, psychotic-like 
symptoms, presence of neurological disorders, times of having been unconscious, and level of 
functioning. 
Educational level was assessed with a self-report questionnaire. Educational level was 
classified 1 (comprehensive school or less) or 2 (matriculation). Full-scale intelligence quotient 
(FSIQ) was assessed using the Vocabulary and Matrix Reasoning Scales of the Wechsler Adult 
Intelligence Scale III (WAIS-III, Finnish Edition) (Wechsler et al., 1997). The validity and 
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reliability of the WAIS-III are demonstrated to be excellent (e.g. Ryan & Ward, 1999). As in 
previous research (e.g. Jukuri et al., 2013), full-scale intelligence quotient was defined as the mean 
of the two scales. 
Smoking status was assessed by asking participants whether they had smoked 
cigarettes regularly during their life (1=no; 2=yes). With regard to alcohol use, participants rated 
the statement of “I drink too much alcohol or get drunk” with a 3-point scale (0=not true; 
1=somewhat or sometimes true; 2=very true or often true). Participants rating “very true or often 
true” were defined to have risky alcohol use.  
Current Axis-I disorders were assessed with Structured Interview for DSM-IV Axis I 
Disorders (SCID-I) (First et al., 2002). The presence of neurological disorders and times of having 
been unconscious were evaluated in the interview of neurological symptoms.  
Psychotic-like symptoms were assessed with the Structured Interview for Prodromal 
Syndromes (SIPS, version 3.0) (Miller et al., 2003). The SIPS measures three separate prodromal 
syndromes: brief intermittent psychotic syndrome, attenuated positive prodromal syndrome, and 
genetic risk and deterioration syndrome. Each participants’ psychotic symptomatology was defined 
as the highest score of the SIPS positive symptoms within the past month, ranging from 0 (absence 
of psychotic symptoms) to 6 (psychosis). This score was further recoded into 4 categories: (i) the 
score of 0 (no psychotic symptoms); (ii) the scores of 12 (mild symptoms); (iii) the scores of 35 
(prodromal symptoms of psychosis); (iv) the score of 6 (psychotic symptoms).  
Level of functioning was evaluated with the Global Assessment of Functioning Scale 
(GAF) (Spitzer et al., 1996). The psychometric properties of the GAF are shown to be adequate 
(Sonesson et al., 2010; Startup et al., 2002). The values of the GAF range from 0 to 100, with a 
higher score of the GAF referring to a higher level of social, occupational, and psychological level 
of functioning.  
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2.3 Brain-imaging methods and data pre-processing 
Resting-state BOLD (Blood Oxygen Level Dependent-signal) data were collected on a General 
Electric Signa 1.5 T whole body system with an eight channel receive coil, using an EPI (Echo 
Planar Imaging) GRE (Gradient Echo) sequence TR (Repetition Time) 1800 ms, TE (Echo Time) 
40 ms, 280 time points, 28 oblique axial slices, slice thickness 4 mm, inter-slice space 0.4 mm, 
covering the whole brain, FOV (Field of View) 25.6 cm × 25.6 cm, with 64 × 64 matrix, parallel 
imaging factor 2, and a flip angle of 90°. T1-weighted scans were imaged using a 3D FSPGR (Fast 
Spoiled Gradient echo) BRAVO (Brain Volume imaging) sequence (TR 12.1 ms, TE 5.2 ms, slice 
thickness 1.0 mm, FOV 24.0 cm, matrix 256 × 256, and flip angle 20°), and NEX (Number of 
Excitations) 1 in order to obtain anatomical images for co-registration of the fMRI data to standard 
space coordinates. For further information, see Jukuri et al. (2013).  
Neuroimaging data were analysed with FSL (http://www.fmrib.ox.ac.uk/fsl, FSL 
5.0.8) 31-36 and AFNI 37. We performed the following steps in preprocessing: brain extraction 
with AFNI’s 3dSkullstrip (Cox, 1996; Smith, 2002), motion correction with MCFLIRT [Jenkinson 
et al., 2002], spatial smoothing with a Gaussian kernel of FWHM 5.0 mm, co-registration with 
FLIRT, non-linear normalization of structural data to 2mm MNI-152 template using 
FNIRT (Jenkinson & Smith, 2001; Jenkinson et al., 2002), and detrending with AFNI’s 3dDetrend 
due to the potential scanner-related effect on standard deviation. Relative and absolute root-mean-
square (RMS) head displacement (millimeter) was determined from FSL's MCFLIRT and used as 
covariates in the model. Average absolute displacement refers to the mean of head motion in fMRI 
time-series in relation to a reference time point (i.e. the first volume in time-series). Average 
relative displacement, in turn, represents the mean head motion in fMRI time-series in relation to 
the subsequent time point. FSL's FAST was used for the segmentation of T1-weighted structural 
images into white matter (WM), grey matter (GM) and cerebrospinal fluid (CSF). 
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 For each study participant, CVBOLD map was calculated as a ratio between standard 
deviation of preprocessed BOLD-time series divided by the mean of preprocessed BOLD-time 
series in each voxel. This method has been used by (Kananen et al., 2018; Jahanian et al., 2017; 
Tuovinen et al., 2017, 2018) and is similar to the method used by (Makedonov et al., 2013, 2016). 
A close concept for CVBOLD is signal-to-noise ratio that is calculated as 1/CVBOLD and has been 
used previously (e.g. Harrison & Weinberger, 2005). Next, we extracted the average CVBOLD in 
WM, GM and CSF (segmented with FSL's FAST). Sex, age, education, absolute and relative 
displacement were used as covariates in the model.   
 
2.4 Statistical analyses 
The statistical analyses were run using STATA SE (version 15.0). The associations of familial risk 
for psychosis and polygenic risk score for schizophrenia with CVBOLD in the brain were investigated 
using linear regression analyses. Familial risk for psychosis and polygenic risk score for 
schizophrenia were added separately to the model. Further, separate models were estimated for 
CVBOLD in CSF, WM, and GM. As additional analyses, all the analyses were run among those 
participants with no psychotic-like symptomatology (the current SIPS score less than 3). All the 
analyses were adjusted for age, sex, educational level, absolute and relative displacement. We 
assessed the level of multicollinearity using the value of VIF (variance inflation factor). VIF values 
less than 10 are stated to indicate low level of multicollinearity (see Alin, 2010). In our analyses, 
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Descriptive statistics of the study variables are shown in Table 1. In the sample, there were 72 
participants (34.3%) with familial risk for psychosis.  
 
[Table 1 about here] 
 
Table 2 shows the results of the regression analyses, when predicting CVBOLD in CSF, WM, and 
GM by familial risk for psychosis. Familial risk for psychosis was not related to CVBOLD in CSF, 
WM, or GM. Table 3 presents the results of the regression analyses, when predicting CVBOLD in 
CSF, WM, and GM by polygenic risk score for schizophrenia. Polygenic risk score for 
schizophrenia was not associated with CVBOLD in CSF, WM, or GM. All the findings were adjusted 
for age, gender, educational level, and absolute and relative displacement.  
 As additional analyses, the regression analyses were rerun among participants without 
psychotic-like symptoms (the current SIPS < 3, N=132 for familial risk analyses, N=133 for PRS 
analyses). All the associations remained non-significant. The results of the additional analyses are 
described with more detail in Supplementary Tables 12. 
 Finally, we investigated the associations of familial risk for psychosis and polygenic 
risk score for schizophrenia with parameters of motion in the fMRI data. Familial risk for psychosis 
was not linked with absolute (beta=-0.093, p=0.283) or relative parameters of motion (beta=0.100, 
p=0.246). Moreover, polygenic risk score was not linked with absolute (beta=-0.064, p=0.439) or 
relative parameters of motion (beta=-0.074, p=0.375). For further information, see Supplementary 
Tables 34. 
 
[Table 2 about here] 
[Table 3 about here] 
 




To the best of our knowledge, this study was the first to investigate whether familial risk for 
psychosis and polygenic risk score for schizophrenia might be related to physiological fluctuation 
(variation of the BOLD signal) in the brain. The results showed that neither familial risk for 
psychosis nor polygenic risk score was associated with lower CVBOLD in cerebrospinal fluid, white 
matter, or grey matter. All the findings were controlled for age, sex, educational level, and absolute 
and relative displacement. Finally, all the results remained non-significant when including only 
those participants with no psychotic-like symptoms (the current SIPS score < 3). Taken together, 
familial or genetic risk for psychosis appeared not to be related to physiological fluctuation 
(variation of the BOLD signal) in the brain.   
Previous studies have shown that physiological fluctuation is related to Alzheimer’s 
disease (Makedonov et al., 2016), acute ischemia (Khalil et al., 2017), epilepsy (Kananen et al., 
2018), schizophrenia (Cheng et al., 2015), and prodromal syndromes of psychosis (Saarinen et al., 
submitted). This study was the first to investigate whether physiological fluctuation in the fMRI 
data is linked with genetic factors. Previously, it has been postulated that genetic vulnerabilities for 
schizophrenia become apparent in specific alterations of the signal-to-noise ratio (Harrison & 
Weinberger, 2005) that refers to the variance of BOLD signal in the brain. However, the present 
study did not provide evidence for this postulation. It seems that the changes in the physiological 
fluctuation of the brain are evident only after the onset of neuropsychiatric diseases. 
The null results about the link between psychosis-related genes and physiological 
fluctuation in the brain may have several explanations. Firstly, there is previous evidence for the 
heritability of heart rate variability (Kupper et al., 2004; Snieder et al., 2007), ambulatory 
cardiorespiratory coupling (Kupper et al., 2005), systemic arterial stiffness (Snieder et al., 2000), 
and respiratory control (Gaultier, 2004). These qualities of cardiorespiratory functioning, in turn, 
                                                                            Genetic susceptibilities and physiological fluctuation  
 11 
are closely related to the amount of physiological fluctuation in the brain (e.g. Birn et al., 2012; 
Cheng et al., 2015; Krüger & Glover, 2001; Murphy et al., 2009; Wise et al., 2004). The current 
study indicates that the genes, which are related to the elements of physiological fluctuation, may 
not be overlapping with the schizophrenia-related genes. Secondly, it may be that schizophrenia-
related genes are linked to physiological fluctuation in the brain only when co-occurring with some 
other genes. For example, one study reported that dopamine-related genes are related to cortical 
signal-to-noise ratio but only in the presence of another genetic polymorphism (in the gene for the 
enzyme catechol-o-methyltransferase) (Winterer & Weinberger, 2003).  
Thirdly, it might be speculated that our null results might be accounted by a 
compensatory effect. That is, for example, individuals with prodromal symptoms have increased 
activity in certain brain regions during prodromal symptoms, but decreased activity during 
improvement of the symptoms (Fusar-Poli et al., 2010). Thus, individuals at risk for psychosis may 
need more neurophysiological effort in order to achieve the same level of brain functioning (Cooper 
et al., 2014). Similarly, some degree of physiological fluctuation (signal-to-noise ratio) appears to 
be necessary for adequate brain functioning (e.g. Birn et al., 2012; Dreha-Kulaczewski et al., 2015; 
Kiviniemi et al., 2016). This is because signal-to-noise ratio partly reflects the rhythm of arterial 
pulsations that, in turn, influences the flow of cerebrospinal fluid into perivascular spaces and 
induce clearance of metabolic waste (Mestre et al., 2018). Accordingly, individuals at genetic risk 
for psychosis might have an innate susceptibility for increased physiological fluctuation in the 
brain, but they might have compensated it and, in this way, captured the “normal” level of 
fluctuation. This might possibly explain why we did not obtain any associations between 
schizophrenia-related genes and alterations in the level of physiological fluctuation.  
This study has some limitations that are necessary to be taken into consideration. 
Firstly, our samples were relatively small in the analyses (N=140149). Previously, it has been 
stated that in the context of complex genetic disorders, a small sample size may result in the lack of 
                                                                            Genetic susceptibilities and physiological fluctuation  
 12 
power to obtain any associations between genetic factors and disease-related neurophysiological 
alterations (Harrison & Weinberger, 2005). In this study, all the associations of familial risk and 
polygenic risk score with CVBOLD in the cerebrospinal fluid, white matter, and grey matter were 
statistically non-significant. However, the null results may not likely be accounted by the relatively 
small sample size because gender, for example, was significantly associated with CVBOLD in the 
brain in our sample.  
Secondly, our sample was relatively heterogeneous, including participants with 
familial risk for psychosis, earlier adolescent attention-deficit hyperactivity disorder, or current 
Axis-I disorder. There is previous evidence that psychotic symptoms have a high comorbidity level 
with other psychiatric and neurological symptoms, for example, depression, anxiety, epilepsy, 
ADHD, and substance use disorders (Fusar-Poli et al., 2012; Gaitatzis et al., 2004; Karatekin et al., 
2010; Keshavan et al., 2003; Schuckit et al., 2006). Hence, excluding all the individuals with any 
other psychiatric or neurological diagnosis might result in a substantial selective bias in the sample 
and limit the generalizability of the findings to other populations. Another possibility might have 
been to control for all the other psychiatric and neurological diagnoses. This method, however, 
would likely have resulted in a large number of covariates and statistical problems with 
multicollinearity. Consequently, we ended up to control for the basic covariates in the analyses (i.e. 
sex, age, educational level, and absolute and relative displacement). 
The current study had also a variety of strengths. Overall, this study was the first to 
investigate whether genetic vulnerabilities for psychosis might be linked with CVBOLD in the brain. 
Additionally, we had two different indicators of genetic vulnerabilities: familial risk for psychosis 
and polygenic risk score for schizophrenia. This is line with a previous statement that when 
investigating neuroimaging-based phenotypes for schizophrenia, it is necessary to obtain the 
findings both among individuals with a high genetic risk score and among first-degree relatives of 
psychotic individuals (Birnbaum & Weinberger, 2013). Secondly, we used whole-brain indicators 
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of CVBOLD in grey matter, white matter, and cerebrospinal fluid, instead of investigating selectively 
some brain regions of interest. Thirdly, familial risk for psychosis was assessed reliably on the basis 
of the Finnish Hospital Discharge Register. The PRS, in turn, was based on a total of 112 SNPs 
derived from genome wide association studies. Fourthly, the NFBC 1986 study provided a sample 
of roughly same-aged participants in their young adulthood. This is in line with previous 
recommendations that the neurophysiological correlates of schizophrenia should be investigated in 
the early adulthood in order to ensure that the findings are present prior to the onset of illness 
(Cooper et al., 2014).  
In conclusion, this study showed that genetic vulnerabilities for schizophrenia were 
not related to physiological fluctuation (amount of variation of the BOLD signal) in the brain. With 
regard to future studies, the measures of CVBOLD are close to the recently detected BOLD delay 
maps in acute ischemia and small vessel disease (see Khalil et al., 2017; Lv et al., 2013; Tong et al., 
2017). Hence, the link of psychosis with the BOLD delay maps could be addressed in the future. 
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Table 1. Means, standard deviations (SD), ranges, and frequencies of the study variables. 
  Mean SD Range Frequency (%) 
Age 22.81 0.80 20.95; 24.64  
Sex (female)    69 (32.9) 
Familial risk for psychosis    72 (34.3) 
Polygenic risk score for schizophrenia 0.05 0.98 -2.10; 2.50  
SIPS positive symptoms     
     No psychotic symptoms    111 (52.9) 
     Mild symptoms    81 (38.6) 
     Prodromal symptoms of psychosis    17 (8.1) 
     Psychosis    1 (0.5) 
Educational level     
     Comprehensive school or less    81 (38.6) 
     University / graduate-level     129 (61.4) 
Smoker    91 (43.3) 
Risky alcohol use    51 (24.3) 
Current Axis-I disorder    37 (26.2) 
Neurological disorder    33 (15.7) 
Current level of functioning 80.97 10.65 21; 96  
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Table 2. Results of linear regression analyses, when predicting CVBOLD in cerebrospinal fluid, white matter, and grey matter by familial risk for 
psychosis. 
   CVBOLD in cerebrospinal fluid   CVBOLD in white matter   CVBOLD in grey matter 
  Beta B p    Beta B p    Beta B p  
Age -0.322 -0.001 <0.001  -0.229 0.000 0.002  -0.172 -0.000 0.014 
Sex1 -0.361 -0.002 <0.001  -0.364 -0.001 <0.001  -0.271 -0.001 <0.001 
Educational level -0.013 0.000 0.853  -0.105 0.000 0.180  -0.032 0.000 0.662 
Absolute displacement -0.198 -0.002 0.006  -0.220 -0.001 0.005  -0.206 -0.001 0.005 
Relative displacement 0.439 0.062 <0.001  0.321 0.023 <0.001  0.548 0.055 <0.001 
Familial risk for psychosis2 -0.135 -0.001 0.050   -0.061 0.000 0.419   -0.096 0.000 0.177 
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Table 3. Results of linear regression analyses, when predicting CVBOLD in cerebrospinal fluid, white matter, and grey matter by polygenic risk 
score for schizophrenia. 
  CVBOLD in cerebrospinal fluid   CVBOLD in white matter   CVBOLD in grey matter 
  Beta B p    Beta B p    Beta B p  
Age -0.279 -0.001 <0.001  -0.225 0.000 0.001  -0.143 0.000 0.016 
Sex1 -0.337 -0.002 <0.001  -0.345 -0.001 <0.00
1 
 -0.282 -0.001 <0.001 
Educational level -0.033 0.000 0.607  -0.146 0.000 0.025  -0.038 -0.000 0.521 
Absolute displacement -0.276 -0.003 <0.001  -0.316 -0.002 <0.00
1 
 -0.287 -0.002 <0.001 
Relative displacement 0.569 0.064 <0.001  0.534 0.033 <0.00
1 
 0.703 0.059 <0.001 
Polygenic risk score  
   for schizophrenia 
-0.041 0.000 0.518  -0.019 0.000 0.771   -0.032 0.000 0.583 
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Supplementary Table 1. Results of linear regression analyses, when predicting CVBOLD in cerebrospinal fluid, white matter, and grey matter by 
familial risk for psychosis among participants with current SIPS < 3. 
 
  CVBOLD in cerebrospinal fluid   CVBOLD in white matter   CVBOLD in grey matter 
  Beta B p    Beta B p    Beta B p  
Age -0.291 -0.001 <0.001  -0.180 0.000 0.019  -0.140 0.000 0.050 
Sex1 -0.382 -0.002 <0.001  -0.375 -0.001 <0.001  -0.287 -0.001 <0.001 
Educational level -0.005 0.000 0.942  -0.108 0.000 0.181  -0.027 0.000 0.720 
Absolute displacement -0.209 -0.002 0.005  -0.235 -0.001 0.004  -0.217 -0.001 0.004 
Relative displacement 0.459 0.064 <0.001  0.341 0.024 <0.001  0.566 0.057 <0.001 
Familial risk for psychosis2 -0.156 -0.001 0.029   -0.073 0.000 0.353   -0.107 0.000 0.144 
1 Male as the reference group. 2 Participants without familial risk for psychosis as the reference group. N=132 
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Supplementary Table 2. Results of linear regression analyses, when predicting CVBOLD in cerebrospinal fluid, white matter, and grey matter by 
polygenic risk score for schizophrenia among participants with current SIPS < 3. 
 
  CVBOLD in cerebrospinal fluid   CVBOLD in white matter   CVBOLD in grey matter 
  Beta B p    Beta B p    Beta B p  
Age -0.291 -0.001 <0.001  -0.225 0.000 <0.001  -0.127 0.000 0.038 
Sex1 -0.338 -0.002 <0.001  -0.352 -0.001 <0.001  -0.290 -0.001 <0.001 
Educational level -0.024 0.000 0.715  -0.145 0.000 0.028  -0.041 -0.002 <0.001 
Absolute displacement -0.268 -0.003 <0.001  -0.311 -0.002 <0.001  -0.284 0.059 <0.001 
Relative displacement 0.594 0.066 <0.001  0.572 0.034 <0.001  0.714 0.059 <0.001 
Polygenic risk score for  
   schizophrenia 
-0.045 0.000 0.485  -0.026 0.000 0.685   -0.031 0.000 0.607 
1 Male as the reference group. 2 The reference group. N=133 
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Supplementary Table 3. Results of linear regression analyses, when predicting absolute and 
relative motion by familial risk for psychosis. 
  Absolute motion   Relative motion 
  Beta B p    Beta B p  
Age -0.067 -0.031 0.439  -0.043 -0.001 0.614 
Sex1 -0.102 -0.074 0.245  -0.077 -0.003 0.379 
Educational level 0.042 0.031 0.639  0.168 0.007 0.059 
Familial risk for psychosis -0.093 -0.066 0.283   0.100 0.004 0.246 
1 Male as the reference group. 2 Participants without familial risk for 
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Supplementary Table 4. Results of linear regression analyses, when predicting absolute and 
relative motion by polygenic risk score for schizophrenia. 
 
  Absolute motion   Relative motion 
  Beta B p    Beta B p  
Age -0.073 -0.029 0.379  0.048 0.002 0.568 
Sex1 -0.156 -0.095 0.064  -0.104 -0.005 0.217 
Educational level 0.051 0.031 0.545  -0.007 0.000 0.931 
Polygenic risk score  
   for schizophrenia 
-0.064 -0.020 0.439  -0.074 -0.002 0.375 
1 Male as the reference group. N=148-149 
 
 
 
 
 
